Mariëtte E. Botes

1.2k total citations
14 papers, 818 citations indexed

About

Mariëtte E. Botes is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Mariëtte E. Botes has authored 14 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 10 papers in Virology and 2 papers in Epidemiology. Recurrent topics in Mariëtte E. Botes's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (10 papers) and HIV/AIDS Research and Interventions (9 papers). Mariëtte E. Botes is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (10 papers) and HIV/AIDS Research and Interventions (9 papers). Mariëtte E. Botes collaborates with scholars based in South Africa, Netherlands and Uganda. Mariëtte E. Botes's co-authors include Raph L Hamers, Kim Sigaloff, Margaret Siwale, Tobias F. Rinke de Wit, Cissy Kityo, Maureen Wellington, Wendy Stevens, Kishor Mandaliya, Carole L. Wallis and Michèle van Vugt and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and The Lancet Infectious Diseases.

In The Last Decade

Mariëtte E. Botes

14 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariëtte E. Botes South Africa 10 740 624 179 64 23 14 818
Rose Mougnutou Cameroon 7 399 0.5× 313 0.5× 124 0.7× 46 0.7× 13 0.6× 8 470
Margaret Siwale Netherlands 16 1.1k 1.5× 910 1.5× 280 1.6× 70 1.1× 30 1.3× 23 1.2k
Kim Steegen South Africa 17 675 0.9× 592 0.9× 117 0.7× 33 0.5× 59 2.6× 43 727
Lingjie Liao China 22 1.2k 1.6× 1.1k 1.7× 333 1.9× 40 0.6× 57 2.5× 98 1.3k
Jean‐Guy Baril Canada 7 528 0.7× 441 0.7× 282 1.6× 30 0.5× 22 1.0× 10 625
Caterina Gori Italy 19 709 1.0× 662 1.1× 176 1.0× 83 1.3× 93 4.0× 41 832
Barbara Gunsenheimer‐Bartmeyer Germany 15 465 0.6× 342 0.5× 297 1.7× 79 1.2× 30 1.3× 45 593
Vincent Habiyambere Switzerland 11 377 0.5× 226 0.4× 151 0.8× 22 0.3× 19 0.8× 14 465
Beth Chaplin United States 14 447 0.6× 374 0.6× 133 0.7× 11 0.2× 30 1.3× 27 549
Zacarias José da Silva Guinea-Bissau 10 264 0.4× 182 0.3× 170 0.9× 66 1.0× 17 0.7× 19 394

Countries citing papers authored by Mariëtte E. Botes

Since Specialization
Citations

This map shows the geographic impact of Mariëtte E. Botes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariëtte E. Botes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariëtte E. Botes more than expected).

Fields of papers citing papers by Mariëtte E. Botes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariëtte E. Botes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariëtte E. Botes. The network helps show where Mariëtte E. Botes may publish in the future.

Co-authorship network of co-authors of Mariëtte E. Botes

This figure shows the co-authorship network connecting the top 25 collaborators of Mariëtte E. Botes. A scholar is included among the top collaborators of Mariëtte E. Botes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariëtte E. Botes. Mariëtte E. Botes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ondoa, Pascale, Andrea A. Kim, T. Sonia Boender, et al.. (2020). Access to HIV Viral Load Testing and Antiretroviral Therapy Switch Practices: A Multicountry Prospective Cohort Study in Sub-Saharan Africa. AIDS Research and Human Retroviruses. 36(11). 918–926. 4 indexed citations
2.
Boender, T. Sonia, Raph L Hamers, Pascale Ondoa, et al.. (2016). Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa. The Journal of Infectious Diseases. 214(6). 873–883. 40 indexed citations
3.
Boender, T. Sonia, Cissy Kityo, Ragna S. Boerma, et al.. (2016). Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa. Journal of Antimicrobial Chemotherapy. 71(10). 2918–2927. 73 indexed citations
4.
Rossouw, Theresa M., et al.. (2016). The end of the line? A case of drug resistance to third-line antiretroviral therapy. Southern African Journal of HIV Medicine. 17(1). 454–454. 5 indexed citations
5.
Boender, T. Sonia, Bernice M. Hoenderboom, Kim Sigaloff, et al.. (2015). Pretreatment HIV Drug Resistance Increases Regimen Switches in Sub-Saharan Africa. Clinical Infectious Diseases. 61(11). 1749–1758. 46 indexed citations
6.
Cooper, David A., Jayvant Heera, Prudence Ive, et al.. (2013). Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1. AIDS. 28(5). 717–725. 30 indexed citations
7.
Eley, Timothy, Shu‐Pang Huang, Francesca Conradie, et al.. (2013). Clinical and Pharmacogenetic Factors Affecting Neonatal Bilirubinemia Following Atazanavir Treatment of Mothers During Pregnancy. AIDS Research and Human Retroviruses. 29(10). 1287–1292. 4 indexed citations
8.
Hamers, Raph L, Hans L. Zaaijer, Carole L. Wallis, et al.. (2013). HIV–HBV Coinfection in Southern Africa and the Effect of Lamivudine- Versus Tenofovir-Containing cART on HBV Outcomes. JAIDS Journal of Acquired Immune Deficiency Syndromes. 64(2). 174–182. 55 indexed citations
9.
Botes, Mariëtte E., et al.. (2012). THE LONG-RUN RELATIONSHIP BETWEEN INFLATION AND REAL STOCK PRICES: EMPIRICAL EVIDENCE FROM SOUTH AFRICA. Journal of Business Economics and Management. 13(4). 600–613. 9 indexed citations
10.
Sigaloff, Kim, Raph L Hamers, Margaret Siwale, et al.. (2012). Early Warning Indicators for Population-Based Monitoring of HIV Drug Resistance in 6 African Countries. Clinical Infectious Diseases. 54(suppl_4). S294–S299. 21 indexed citations
11.
Sigaloff, Kim, Raph L Hamers, Carole L. Wallis, et al.. (2011). Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(1). 23–31. 151 indexed citations
12.
Hamers, Raph L, Carole L. Wallis, Cissy Kityo, et al.. (2011). HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. The Lancet Infectious Diseases. 11(10). 750–759. 228 indexed citations
13.
Hamers, Raph L, Rob Schuurman, Kim Sigaloff, et al.. (2011). Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study. The Lancet Infectious Diseases. 12(4). 307–317. 141 indexed citations
14.
Botes, Mariëtte E., et al.. (2002). Phase I trial with oral oxihumate in HIV‐infected patients. Drug Development Research. 57(1). 34–39. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026